Apoprotein-B binding sites in estrogen-treated rabbit liver: quantitative immunoelectron microscopy

Area of Science:

• Lipid metabolism and lipoprotein research
• Endocrinology and liver physiology
• Cellular biology and receptor-mediated endocytosis

Background:

• Apolipoprotein (Apo)-B lipoproteins are crucial for lipid transport.
• Estrogen's effects on hepatic lipoprotein metabolism are complex and not fully understood.
• Previous studies indicated estrogen alters apolipoprotein E (Apo-E) distribution in the liver.

Purpose of the Study:

• To investigate the impact of estrogen on the binding and cellular distribution of apolipoprotein (Apo)-B containing lipoproteins in rabbit hepatocytes.
• To elucidate the mechanisms underlying estrogen's influence on Apo-B lipoprotein uptake.

Main Methods:

• Perfusing normal and estrogen-treated rabbit livers with iodinated very low density lipoproteins (125I-VLDL).
• Utilizing quantitative immunoelectron microscopy and autoradiography to analyze Apo-B binding and cellular localization.
• Quantifying the number of endocytotic pits and vesicles involved in lipoprotein internalization.

Main Results:

• Estrogen treatment resulted in a 2-fold increase in the binding of Apo-B containing particles to hepatocytes.
• Apo-B containing particles were internalized via endocytosis, involving endocytotic pits and vesicles.
• Estrogen significantly increased the number of endocytotic pits, correlating with enhanced Apo-B binding and internalization.
• Unlike Apo-E, the hepatic distribution of Apo-B was not affected by estrogen treatment.

Conclusions:

• Estrogen administration stimulates the binding and internalization of Apo-B lipoproteins in rabbit hepatocytes.
• The mechanism involves an estrogen-induced increase in the formation of endocytotic structures.
• Estrogen's regulatory effects on lipoprotein metabolism are specific, impacting Apo-B uptake but not its overall liver distribution.